1
General questions

How do protein-based vaccines work?

3:44
3568
Views
27
Likes
3/17/2023

Rather than injecting a whole pathogen to trigger an immune response, subunit vaccines (sometimes called acellular vaccines) contain purified pieces of it, which have been specially selected for their ability to stimulate immune cells. Because these fragments are incapable of causing disease, subunit vaccines are considered very safe. There are several types: protein subunit vaccines contain specific isolated proteins from viral or bacterial pathogens; polysaccharide vaccines contain chains of sugar molecules (polysaccharides) found in the cell walls of some bacteria; conjugate subunit vaccines bind a polysaccharide chain to a carrier protein to try and boost the immune response. Only protein subunit vaccines are being developed against the virus that causes COVID-19.

Other subunit vaccines are already in widespread use. Examples include the hepatitis B and acellular pertussis vaccines (protein subunit), the pneumococcal polysaccharide vaccine, and the MenACWY vaccine, which contains polysaccharides from the surface of four types of the bacteria that causes meningococcal disease joined to diphtheria or tetanus toxoid (conjugate subunit).

Subunit vaccines contain fragments of protein and/or polysaccharide from the pathogen, which have been carefully studied to identify which combinations of these molecules are likely to produce a strong and effective immune response. By restricting the immune system’s access to the pathogen in this way, the risk of side effects is minimized. Such vaccines are also relatively inexpensive and easy to produce, and more stable than those containing whole viruses or bacteria.

A downside of this precision is that the antigens used to elicit an immune response may lack molecular structures called pathogen-associated molecular patterns, which are common to a class of pathogen. These structures can be read by immune cells and recognized as danger signals, so their absence may result in a weaker immune response. Also, because the antigens do not infect cells, subunit vaccines mainly only trigger antibody-mediated immune responses. Again, this means the immune response may be weaker than with other types of vaccines. To overcome this problem, subunit vaccines are sometimes delivered alongside adjuvants (agents that stimulate the immune system) and booster doses may be required.

Update (March 2023): One protein based vaccine (Nuvaxovid / Covovax) has been granted WHO Emergency Use Listing.

Tags

COVID-19 vaccines and vaccination explained – Introduction

2:39

Vaccines protect against severe COVID-19 disease.

1:22

Why are some vaccinated people also hospitalized with COVID-19?

0:58

How could vaccines be developed at record speed while still maintaining quality and safety?

2:29

What are clinical trials and are they enough to prove a vaccine is safe?

3:21

How do mRNA vaccines, like Pfizer-BioNTech and Moderna COVID-19 vaccines, work?

2:13

How do vector vaccines work?

0:58

How should we respond to claims that the mRNA vaccines could cause a genetic change and that we will see this in the coming decades?

2:36

How do protein-based vaccines work?

3:44

How do I know which COVID-19 vaccine to choose or recommend?

0:48

What tests or examinations should people get before COVID-19 vaccination?

0:57

Can a new variant of the SARS-CoV-2 virus cause more severe disease?

1:40

Why should older adults get vaccinated?

1:33

If COVID-19 becomes endemic will vaccination still be needed?

1:01

Why is it necessary to stay in the healthcare facility 15-30 minutes following COVID-19 vaccination?

1:42

Is it possible to catch COVID-19 during an immunization visit to a healthcare facility?

1:12

What are the so-called COVID-19 bivalent booster vaccines?

5:07

What is the recommended use of updated bivalent COVID-19 booster vaccines?

2:15

How do the updated bivalent COVID-19 vaccines work?

1:52

Who should get a COVID-19 booster dose in fall/winter 2023-2024?

0:26

Why is COVID-19 vaccination no longer offered to healthy adults under 60 in some countries?

0:19

Should children get a COVID-19 booster?

0:33

Is it better to wait to get a COVID-19 vaccine that is adapted to currently circulating variants?

0:26

Who should get COVID-19 vaccination booster doses?

1:03